← stocks-llm New chat

GERON CORP (GERN) — insider trading

Health Care · NASDAQ

GERON CORP (GERN) has 10 reported SEC Form 4 insider transactions in our data (latest 2026-06-30).

Recent Form 4 transactions

DateInsiderRoleTypeSharesPriceValueFiling
2026-06-30 Spiegel Robert J. Director Grant / award / vesting 6,103 $1.28 $7.8K Form 4
2026-05-20 Bir Dawn Carter Director Grant / award / vesting (derivative) 220,000 $0.00 $0 Form 4
2026-05-20 McDonald John F Director Grant / award / vesting (derivative) 220,000 $0.00 $0 Form 4
2026-05-20 Molineaux Susan Director Grant / award / vesting (derivative) 220,000 $0.00 $0 Form 4
2026-05-20 O'Farrell Elizabeth G. Director Grant / award / vesting (derivative) 220,000 $0.00 $0 Form 4
2026-05-20 Spiegel Robert J. Director Grant / award / vesting (derivative) 220,000 $0.00 $0 Form 4
2026-04-13 Williams Timothy Officer (EVP and Chief Legal Officer) Grant / award / vesting (derivative) 2,500,000 $0.00 $0 Form 4
2026-03-31 Spiegel Robert J. Director Grant / award / vesting 5,243 $1.49 $7.8K Form 4
2026-03-25 Andrews Patricia S Director Grant / award / vesting (derivative) 270,000 $0.00 $0 Form 4
2026-03-25 Chinoporos Constantine Director Grant / award / vesting (derivative) 270,000 $0.00 $0 Form 4

Ask the chat about GERN's insider activity →

Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.

Source: SEC EDGAR Form 3/4/5. See the full company profile: GERON CORP (GERN).

Last updated 2026-06-30 (most recent filing date).

Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.